WWOX in biological control and tumorigenesis

Area of Science:

• Genetics and Molecular Biology
• Cancer Research
• Biochemistry

Background:

• The WW domain-containing oxidoreductase (WWOX) gene, located at 16q23.1-16q23.2, is associated with the FRA16D fragile site.
• WWOX protein structure includes two WW domains and a short-chain oxidoreductase-like domain.
• Inactivation of WWOX has been observed in numerous human malignancies.

Purpose of the Study:

• To review recent advancements in understanding the tumor suppressor function of WWOX.
• To consolidate evidence on WWOX's role in preventing cancer development.

Main Methods:

• Review of existing literature on WWOX gene and protein.
• Analysis of biochemical interactions defining WWOX's molecular mechanisms.
• Examination of in vivo studies, including genetically modified mouse models.

Main Results:

• Biochemical studies have identified WWOX interacting partners, elucidating its molecular pathways.
• Targeted deletion of the Wwox gene in mice resulted in a higher incidence of spontaneous and chemically induced tumors.
• These findings provide the first in vivo evidence supporting WWOX as a tumor suppressor.

Conclusions:

• WWOX functions as a critical tumor suppressor.
• Further research into WWOX mechanisms can inform cancer prevention and treatment strategies.